Four newly inducted members represent the
lived experience of lung cancer, advocacy, health equity, and
business leadership
WASHINGTON, July 22,
2024 /PRNewswire/ -- Today, LUNGevity Foundation, the
nation's leading nonprofit dedicated to transforming how people are
diagnosed and live with lung cancer through research, education,
and support, is proud to announce the expansion of its Board
of Directors. The four new members are Bob
Newman, chairman of ASM Global; Terri Ann DiJulio, three-time lung cancer
survivor and advocate; Barry Nelson,
retired risk management professional and lung cancer survivor; and
Frank Sierawski, general director of
Union Pacific Railroad and long-term lung cancer survivor.
"We're honored to have such committed and passionate advocates
for cancer patients join our Board," said Andrea Ferris, president and CEO of LUNGevity.
"I'm excited to see the real impact we can have together for our
community as we work to transform lung cancer."
Bob Newman, chairman of
ASM Global, is one of the most respected executives in the venue
industry and has a proven track record of building facility
management teams that serve the entertainment, professional and
amateur sports, meetings, and exhibitions in both the public and
private sectors. He has stewarded the company's rise to the
worldwide leading provider of innovative venue services and live
experiences. Bob has a personal family connection to cancer that
motivates his advocacy and philanthropy. He received his BS in
marketing from the University of
Connecticut and an MS in sport management from the
University of Massachusetts.
Terri Ann DiJulio is a
three-time lung cancer survivor, a stroke survivor, and a member of
a multigenerational lung cancer family. She has been a featured
speaker at many conferences and events, has spoken on Capitol Hill,
has been interviewed by the Wall Street Journal, among
numerous other publications, and is an active lung cancer blogger.
Terri Ann is on the LUNGevity Early
Lung Cancer Center's External Advisory Board and spoke at its
initial meeting. She actively promotes early detection through her
speaking events and media platforms and shares how her experiences
have profoundly changed her perspective and gratitude for every
day.
Barry Nelson is a
retired risk management professional who has found meaning in his
lung cancer diagnosis through passionate advocacy. He is
an experienced speaker at conferences, where he draws from his
personal journey as a cancer survivor and clinical trial
participant. Barry is a committee member of the Partners in
Clinical Research Conference and the Patient Advisory Council at
Kyruus Health, and he co-creates projects for Patient-Centered
Outcomes Research Initiatives (PCORI). He volunteers with
Dana-Farber Cancer Institute as a community ambassador and on a
community level in Boston to
educate black men about lung cancer. Barry received a BS in
business administration from Eastern Nazarene
College.
Frank Sierawski,
general director of Union Pacific Railroad, is a 10+ year
late-stage lung cancer survivor who has been the beneficiary of
biomarker testing and breakthrough technologies. Continued use
of a targeted therapy has kept him with no evidence of disease
since 2017. He attends the annual LUNGevity Scientific and Clinical
Roundtable to represent the patient voice. Frank actively advocates
for LUNGevity and the ALK+ lung cancer community and calls on
industry, regulators, and fellow patients to challenge the status
quo and explore what's possible. He received a BSBA in accounting
from Creighton University and an MBA
from the University of Nebraska at
Omaha.
About LUNGevity Foundation
LUNGevity, the nation's leading lung cancer organization, is
transforming what it means to be diagnosed and live with lung
cancer. LUNGevity seeks to have an immediate impact on quality of
life and survivorship for everyone touched by the disease—while
promoting health equity by addressing disparities throughout the
care continuum.
- Through research, we use an innovative and holistic
approach to finding lung cancer earlier when it is most treatable;
advance research into new treatments so people may live longer and
better; and ensure a diverse, vital pipeline of investigators for
the future of the lung cancer field.
- Through advocacy, we foster groundbreaking
collaborations to ensure all people have access to screening,
biomarker testing, and treatment breakthroughs.
- Through community, we educate, support, and connect
people affected by lung cancer so that they can get the best
healthcare and live longer and better lives.
Comprehensive resources include a medically vetted and
patient-centric website, Patient Gateways for specific types of
lung cancer, a toll-free HELPLine for personalized support,
international survivor conferences, and tools to find a clinical
trial. All these programs are designed to help us achieve our
vision—a world where no one dies of lung cancer. LUNGevity
Foundation is proud to be a four-star Charity Navigator
organization.
Please visit www.LUNGevity.org to learn
more.
About Lung Cancer in the US
- About 1 in 16 Americans will be diagnosed with lung cancer in
their lifetime.
- More than 238,000 people in the US will be diagnosed with lung
cancer this year.
- About 60%-65% of all new lung cancer diagnoses are among people
who have never smoked or are former smokers.
- Lung cancer causes more deaths than the next two deadliest
cancers (colorectal and pancreatic) combined.
- Only 25% of all people diagnosed with lung cancer will survive
5 years or more, but if it's caught before it spreads, the chance
of 5-year survival improves dramatically.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/lungevity-foundation-expands-its-board-to-accelerate-transforming-lung-cancer-302202952.html
SOURCE LUNGevity Foundation